Multi-target TMS for Schizophrenia Negative Symptoms

Recruiting N/A Interventional Study
SCHIZOPHRENIA 1 (Disorder)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 – 45
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
64 (estimated)
Sponsor
Shanghai Mental Health Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This randomized controlled trial (RCT) is the first to evaluate the efficacy and safety of a multi-target TMS protocol targeting the left dorsolateral prefrontal cortex (L-DLPFC), left inferior parietal lobule (L-IPL), and right orbitofrontal cortex (R-OFC) for negative symptoms of schizophrenia.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Outpatients or inpatients at the Department of Psychiatry, Shanghai Mental Health Center; 2. Meet the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for first-episode schizophrenia (diagnosed using the Structured Clinical Interview for DSM…
Contacts

Huiru Cui, Ph.D

+86 21 34773230

cuihuiru@163.com

CONTACT